The only way to treat the problem used to be by using a laser, though it has been shown to work only in about half the cases. Now there are chemical and laser-related options, too. Because blood vessel growth is associated with the presence of a ‘vascular endothelial growth factor,’ drugs that impair its function are expected to help. Another solution is to use modified RNA (ribonucleic acid) or sealing blood vessel leaks using lasers. Wet macular degeneration occurs to just 15 per cent of the people with age-related macular problems but are common in two-thirds of the people with a significant loss of vision. In 70 per cent of the cases, wet age-related macular degeneration weakens vision to 20/200 or worse within two years. Antioxidants (including vitamins A, C, and E, selenium, copper, lutein, and zeaxanthine) and zinc have been shown to help preserve vision. And it would help to make full use of vision from outside the central zone, that is, the peripheral vision, to maximum effect. Anti oxidants are known to protect by preventing free oxygen – which is found in high quantities in the blood vessel -rich eye.
For more information go to www.maculardegenerationassociation.org
Friday, January 22, 2010
Sunday, January 10, 2010
How to Treat Macular Degeneration with Vitamins
A popular treatment for Macular Degeneration is the use of vitamins, also known as Vitamin Therapy. Below are the popular vitamins that can be used to help treat Macular Degeneration. These vitamins can also be used to help prevent Macular Degeneration.
Step 1
Take a high potency Multivitamin. High potency Multivitamins provide the basic vitamins needed for eye health and can help to prevent future damage with Macular Degeneration.
Step 2
Take 45 mg of Zinc twice per day. Take each dosage along with 2 mg of Copper. Zinc is a necessary vitamin in proper vision and is also a strong antioxidant. Zinc has been proven to be effective in helping to patients with Macular Degeneration.
Step 3
Take 400 IU of a Vitamin E-Complex daily. Vitamin E-Complex works as an antioxidant and has been proven to help improve the vision in patients with Macular Degeneration that is age related. Always take your Vitamin E-Complex with a meal.
For more information go to WWW.MACULARDEGENERATIONASSOCIATION.ORG
Step 1
Take a high potency Multivitamin. High potency Multivitamins provide the basic vitamins needed for eye health and can help to prevent future damage with Macular Degeneration.
Step 2
Take 45 mg of Zinc twice per day. Take each dosage along with 2 mg of Copper. Zinc is a necessary vitamin in proper vision and is also a strong antioxidant. Zinc has been proven to be effective in helping to patients with Macular Degeneration.
Step 3
Take 400 IU of a Vitamin E-Complex daily. Vitamin E-Complex works as an antioxidant and has been proven to help improve the vision in patients with Macular Degeneration that is age related. Always take your Vitamin E-Complex with a meal.
For more information go to WWW.MACULARDEGENERATIONASSOCIATION.ORG
Monday, January 4, 2010
Gene therapy to restore and improve vision
Reduced vision, or even my blindness for an individual there are a number of reasons. The treatment is on what is the case depends, and the effectiveness of treatment. Conventional, non-invasive treatment has always wear glasses or contact lenses to correct vision problems. Developed over time, improving the eye-glass lenses and contacts that reduce glare, the wavelengths of the light side to improve depth perception, and to address many environmental problems.
More recently,There have been new developments in medical care for the blind have been. For example, Avastin, a drug that was originally intended, Colo-rectal cancer treatment has been found to improve vision in patients with macular degeneration, diabetic retinopathy and other retinal vascular disease in context. Non-steroidal anti-inflammatory drugs may reduce inflammation of the retina, and the formation of cysts. The new drugs have been developed to treat infections of cold cuts.
A majorChallenge has been on treatment options for genetic diseases and defects. These diseases result from the patient, and therefore limited treatment options. The future seems to be gene therapy. Recent clinical trials at the Scheie Eye Institute in Philadelphia made using gene therapy have dramatically improved sight-reading by the gesture declaration of letters on a table eye. These tests were sent to people who suffer from a congenital disease has been carriedLeber congenital amaurosis known. The study was later published in The New England Journal of Medicine. This implies a particular eye disease by a mutation in the gene RPE-65. This mutation prevents the gene is required for the production of a protein in the manufacture of the RPE. This protein is required for binding to the tissue of the retina and the light in sight.
The treatment included injection of normal RPE-65 gene directly into the retina. Two weeksthe contribution of all patients showed a better view. In addition, all participants were more sensitive to light. As a result the increase in visual acuity, there was a simultaneous decrease in abnormal eye movements, see further increases the ability of the eye.
While these studies have been performed on patients with a congenital disorder, there is no hope, other people with genetic diseases that help is on the move. With a little luck ', a disease of the retinathe past, because improving the methods of treatment.
For more information go to www.maculardegenerationassociation.org
More recently,There have been new developments in medical care for the blind have been. For example, Avastin, a drug that was originally intended, Colo-rectal cancer treatment has been found to improve vision in patients with macular degeneration, diabetic retinopathy and other retinal vascular disease in context. Non-steroidal anti-inflammatory drugs may reduce inflammation of the retina, and the formation of cysts. The new drugs have been developed to treat infections of cold cuts.
A majorChallenge has been on treatment options for genetic diseases and defects. These diseases result from the patient, and therefore limited treatment options. The future seems to be gene therapy. Recent clinical trials at the Scheie Eye Institute in Philadelphia made using gene therapy have dramatically improved sight-reading by the gesture declaration of letters on a table eye. These tests were sent to people who suffer from a congenital disease has been carriedLeber congenital amaurosis known. The study was later published in The New England Journal of Medicine. This implies a particular eye disease by a mutation in the gene RPE-65. This mutation prevents the gene is required for the production of a protein in the manufacture of the RPE. This protein is required for binding to the tissue of the retina and the light in sight.
The treatment included injection of normal RPE-65 gene directly into the retina. Two weeksthe contribution of all patients showed a better view. In addition, all participants were more sensitive to light. As a result the increase in visual acuity, there was a simultaneous decrease in abnormal eye movements, see further increases the ability of the eye.
While these studies have been performed on patients with a congenital disorder, there is no hope, other people with genetic diseases that help is on the move. With a little luck ', a disease of the retinathe past, because improving the methods of treatment.
For more information go to www.maculardegenerationassociation.org
Subscribe to:
Posts (Atom)